Spots Global Cancer Trial Database for antimitotic agent
Every month we try and update this database with for antimitotic agent cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
A Placebo Controlled Study Comparing AZD1775+ Docetaxel Versus Placebo+Docetaxel to Treat Lung Cancer | NCT02087176 | Previously Trea... | AZD1775 AZD1775 Placebo Antimitotic Age... pegfiligrastim | 18 Years - | AstraZeneca | |
Monotherapy With Eribulin In Her2 Negative Metastatic Breast Cancer as a First Line Treatment | NCT02061085 | Breast Neoplasm Metastasis | Eribulina | 18 Years - | MedSIR | |
Monotherapy With Eribulin In Her2 Negative Metastatic Breast Cancer as a First Line Treatment | NCT02061085 | Breast Neoplasm Metastasis | Eribulina | 18 Years - | MedSIR |